MediciNova, Inc. Provides Corporate Update and Highlights Ongoing Clinical Trials for MN166 and Other Programs
MediciNova updates shareholders on clinical trials and strategic collaborations for neurodegenerative diseases and inflammatory conditions.Quiver AI SummaryMediciNova, Inc., a biopharmaceutical company...
MediciNova, Inc. Receives Notice of Allowance for Patent on MN-001 Method to Decrease Triglyceride Synthesis in the Liver
MediciNova announces patent allowance for MN-001, a method to reduce liver triglyceride synthesis, aiding metabolic disorder treatments.Quiver AI SummaryMediciNova, Inc. has announced that it received...
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday
Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.